Prevalence, treatment rates and control of dyslipidemia among diabetes patients in northern Nigeria: A cross-sectional, multicenter study.

Three-fifths of patients had dyslipidemia, but only a sixth attained the treatment target.

Treatment for dyslipidemia included statins and fibrates, but not niacin, ezetimibe, bempedoic acid, icosapent ethyl, inclisiran or PCSK9 inhibitors recommended for those who failed intensive statin therapy.

There is the need for better access to non-statin treatment and physician adherence to clinical practice guidelines.